Oxidative Stress Mechanisms in Schizophrenia Pathophysiology

Schizophrenia is increasingly understood as a disorder in which disrupted redox homeostasis contributes to aberrant neurodevelopment and synaptic function. Genetic susceptibility, environmental insults and neurotransmitter dysregulation converge on an oxidative stress “hub” that impairs antioxidant defences, notably glutathione-dependent systems, and fosters mitochondrial dysfunction. This pro-oxidant state preferentially damages fast-spiking parvalbumin interneurons, undermining cortical synchrony and cognitive processes. Simultaneously, oxidative signals interact with neuroinflammatory pathways, amplifying matrix metalloproteinase activation and receptor for advanced glycation end-products shedding, which in turn perpetuate oxidative and inflammatory loops. Together, these mechanisms shape the onset and progression of psychotic symptoms and offer targets for redox-based stratification and intervention.

Research from Nature Portfolio

Foundational work has demonstrated that synaptic activity through N-methyl-D-aspartate receptor signalling orchestrates a transcriptional programme enhancing glutathione synthesis, thereby matching antioxidant capacity to neuronal demand. This cell-autonomous regulation, allied with astrocyte-derived Nrf2-driven support, prevents reactive oxygen species accumulation and apoptosis during critical periods of brain development. Disruption of this mechanism, as modelled by NMDAR hypofunction, links early redox imbalance to neurodevelopmental trajectories reminiscent of schizophrenia, providing a molecular framework for redox-guided therapies.

Oxidative Stress Mechanisms in Schizophrenia Pathophysiology publication trend

The graph below shows the total number of articles in oxidative stress mechanisms in schizophrenia pathophysiology across all publications each year (not limited to Nature Index journals).

Technical terms

Oxidative stress: An imbalance between production of reactive oxygen species and the ability of antioxidant defences to neutralise them.

Reactive oxygen species (ROS): Chemically reactive molecules containing oxygen, capable of damaging proteins, lipids and nucleic acids.

Glutathione (GSH): A tripeptide antioxidant that detoxifies ROS and maintains redox signalling within cells.

N-methyl-D-aspartate receptor (NMDAR): A glutamate-gated ion channel critical for synaptic plasticity and activity-dependent gene expression.

Parvalbumin interneurons (PVIs): Fast-spiking inhibitory neurons particularly vulnerable to redox imbalance and essential for cortical oscillations.

Nuclear factor erythroid 2–related factor 2 (Nrf2): A transcription factor that induces expression of antioxidant and cytoprotective genes in response to oxidative stress.

Matrix metalloproteinase 9 (MMP9): A protease activated by oxidative and inflammatory signals, involved in extracellular matrix remodelling and cytokine release.

Receptor for advanced glycation end-products (RAGE): A pattern-recognition receptor that mediates inflammatory and oxidative stress signalling in neurons and glia.

References

1. Characterization of early psychosis patients carrying a genetic vulnerability to redox dysregulation: a computational analysis of mechanism-based gene expression profile in fibroblasts. Molecular Psychiatry (2023).
2. Measurement of brain glutathione with magnetic Resonance spectroscopy in Schizophrenia-Spectrum disorders — A systematic review and Meta-Analysis. Brain Behavior and Immunity (2023).
3. Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system. Nature Communications (2015).
4. MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients. Molecular Psychiatry (2019).